Adapsyn Bioscience is a chemical bioinformatics company focused on discovering and developing novel bacterial metabolites for therapeutic use. Founded in 2016, the company uses a next-generation bioinformatics platform powered by proprietary machine learning to identify new natural product drug candidates from microbial genomes. Adapsyn’s work is published in top scientific journals, and it collaborates with leading pharmaceutical companies while developing an internal pipeline of therapeutic ca